MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration

IntroductionThe miR-183/-96/-182 cluster is a conserved polycistronic microRNA (miRNA) cluster which is highly expressed in most breast cancers. Although there are some sporadic reports which demonstrate the importance of each miRNA in this cluster in breast cancer, the biological roles of this cluster as a whole and its regulation mechanisms in breast cancer are still unclear. We compared the expression of this cluster in different cancer types, analyzed the regulation mechanism of this cluster, identified new target genes, and examined the impact of this cluster on breast cancer cells.MethodsThe miRNA level was detected by LNA-based northern blot and Real-time PCR, and was also analyzed from TCGA dataset. Bioinformatics research and luciferase assay were applied to find the promoter regions and transcription factors. To investigate the biological effects of the miR-183/-96 /-182 cluster in breast cancer, we generated miR-96, miR-182 and miR-183 overexpression stable cell lines to check the overdose effects; we also used miR-Down™ antagomir for each miRNA as well as miR-183/-96 /-182 cluster sponge lentivirus to check the knockdown effects. Growth, migration, cell cycle profile and survival of these cells was then monitored by colony formation assay, MTT assay, cell wound healing assay, flow cytometry and microscopy. The target gene was validated by Real-time PCR, luciferase assay, Western blot and Phalloidin/DAPI counterstaining.ResultsThe miR-183/-96/-182 cluster was highly expressed in most breast cancers, and its transcription is disordered in breast cancer. The miR-183/-96/-182 cluster was transcribed in the same pri-miRNA and its transcription was regulated by ZEB1 and HSF2. It increased breast cell growth by promoting more rapid completion of mitosis, promoted cell migration and was essential for cell survival. MiR-183 targeted the RAB21 mRNA directly in breast cancer.ConclusionThe miR-183/-96/-182 cluster is up-regulated in most breast cancer. It functions as an oncogene in breast cancer as it increases cell proliferation and migration.

[1]  Jun S. Song,et al.  Chromatin structure analyses identify miRNA promoters , 2008 .

[2]  Fei Li,et al.  Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. , 2010, Biochemical and biophysical research communications.

[3]  T. Salminen,et al.  Heterotrimerization of heat-shock factors 1 and 2 provides a transcriptional switch in response to distinct stimuli. , 2009, Molecular biology of the cell.

[4]  Jia Yu,et al.  miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. , 2010, Cancer research.

[5]  Libing Song,et al.  TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets. , 2012, The Journal of clinical investigation.

[6]  Sanghyuk Lee,et al.  MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.

[7]  O. Kallioniemi,et al.  Integrin trafficking regulated by Rab21 is necessary for cytokinesis. , 2008, Developmental cell.

[8]  J. Foekens,et al.  miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs , 2013, Breast Cancer Research.

[9]  Margaret S. Ebert,et al.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.

[10]  R. Deng,et al.  Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis , 2014, Oncogene.

[11]  Libing Song,et al.  Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a , 2010, PloS one.

[12]  A. Osunkoya,et al.  Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells , 2009, Breast Cancer Research and Treatment.

[13]  K. Palczewski,et al.  Sponge Transgenic Mouse Model Reveals Important Roles for the MicroRNA-183 (miR-183)/96/182 Cluster in Postmitotic Photoreceptors of the Retina* , 2011, The Journal of Biological Chemistry.

[14]  Gretchen L. Gierach,et al.  Association between mammographic density and basal-like and luminal A breast cancer subtypes , 2013, Breast Cancer Research.

[15]  Ying Chang,et al.  Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells. , 2013, Oncology reports.

[16]  Yan Wang,et al.  Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1 , 2013, Tumor Biology.

[17]  D. Polsky,et al.  Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor , 2009, Proceedings of the National Academy of Sciences.

[18]  D. Valle,et al.  MicroRNA (miRNA) Transcriptome of Mouse Retina and Identification of a Sensory Organ-specific miRNA Cluster* , 2007, Journal of Biological Chemistry.

[19]  Anton J. Enright,et al.  Genomic analysis of human microRNA transcripts , 2007, Proceedings of the National Academy of Sciences.

[20]  K. Sarge,et al.  HSF2 binds to the Hsp90, Hsp27, and c-Fos promoters constitutively and modulates their expression , 2007, Cell stress & chaperones.

[21]  Kenneth P. Nephew,et al.  RNA Polymerase II Binding Patterns Reveal Genomic Regions Involved in MicroRNA Gene Regulation , 2010, PloS one.

[22]  Subbaya Subramanian,et al.  MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. , 2010, Cancer research.

[23]  Tzong-Yi Lee,et al.  Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data , 2011, Nucleic acids research.

[24]  Nicholas T. Ingolia,et al.  Mammalian microRNAs predominantly act to decrease target mRNA levels , 2010, Nature.

[25]  Michael J Kerin,et al.  Dysregulated miR-183 inhibits migration in breast cancer cells , 2010, BMC Cancer.

[26]  Y. Takai.  Faculty Opinions recommendation of Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of beta1-integrins. , 2006 .

[27]  O. Kallioniemi,et al.  Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo , 2011, Oncogene.

[28]  M. Hou,et al.  Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. , 2013, Biochimica et biophysica acta.

[29]  J. Steen,et al.  Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma , 2012, Acta Neuropathologica.

[30]  Junfeng Zhu,et al.  Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. , 2012, The American journal of pathology.

[31]  Jining Lu,et al.  Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer , 2011, Breast Cancer Research.

[32]  B. White,et al.  Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells , 2009, The Journal of Biological Chemistry.

[33]  Jason I. Herschkowitz,et al.  Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer , 2010, Breast Cancer Research.

[34]  André Kajdacsy-Balla,et al.  miR-183-96-182 Cluster Is Overexpressed in Prostate Tissue and Regulates Zinc Homeostasis in Prostate Cells* , 2011, The Journal of Biological Chemistry.

[35]  Naomi B Dillner,et al.  Transcriptional activation by the zinc-finger homeodomain protein delta EF1 in estrogen signaling cascades. , 2004, DNA and cell biology.

[36]  T. Pellinen,et al.  Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of β1-integrins , 2006, The Journal of cell biology.

[37]  Robert A. Weinberg,et al.  Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity , 2013, Cell.

[38]  Xiaofei Zheng,et al.  miR-183 inhibits TGF-β1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells , 2010, BMC Cancer.

[39]  A. Dimmler,et al.  The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. , 2008, Cancer research.